home / stock / tela / tela news

TELA News and Press, TELA Bio Inc. From 05/25/23

Stock Information
Company Name: TELA Bio Inc.
Stock Symbol: TELA
Market: NYSE
Website: telabio.com
Menu
TELA TELA Quote TELA Short TELA News TELA Articles TELA Message Board
Get TELA Alerts

News, Short Squeeze, Breakout and More Instantly...
TELA - TELA Bio to Participate in the Jefferies Global Healthcare Conference

MALVERN, Pa., May 25, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own a...
TELA - TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

MALVERN, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, t...

TELA - TELA Bio, Inc. (TELA) Q1 2023 Earnings Call Transcript

2023-05-14 12:21:07 ET TELA Bio, Inc. (TELA) Q1 2023 Earnings Conference Call May 11, 2023 04.30 PM ET Company Participants Louisa Smith - Gilmartin Group Tony Koblish - President and CEO Roberto Cuca - COO and CFO Conference Call Participants Kyle Ro...

TELA - TELA Bio GAAP EPS of -$0.63 misses by $0.04, revenue of $11.9M in-line

2023-05-11 16:13:08 ET TELA Bio press release ( NASDAQ: TELA ): Q1 GAAP EPS of -$0.63 misses by $0.04 . Revenue of $11.9M (+44.6% Y/Y) in-line. 2023 Financial Guidance We continue to expect full year 2023 revenue to range from $60 million to $65 million vs $61....
TELA - TELA Bio Reports First Quarter 2023 Financial Results

MALVERN, Pa., May 11, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anat...

TELA - TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient...

TELA - TELA Bio to Participate in the JMP Securities Life Sciences Conference

MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own a...
TELA - TELA Bio to Announce First Quarter 2023 Financial Results

MALVERN, Pa., April 27, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the p...

TELA - XPEV, HIVE and BTBT among pre-market losers

2023-04-19 08:21:42 ET Allarity Therapeutics ( ALLR ) -33% . Femasys ( FEMY ) -25% anounces $3.9 million registered direct offering. Oblong ( OBLG ) -21% . Gamida Cell ( GMDA ) -16% on public offering . United Insurance Holdings ( ...

TELA - TELA prices $45M public offering

2023-04-19 05:00:09 ET Commercial-stage medical technology company, TELA ( NASDAQ: TELA ) announced underwritten public offering of 4.75M shares at a price to the public of $9.50 per share. Gross proceeds of $45.125M. Underwriters have a 30-day option to purchase up to...
Previous 10 Next 10